{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:22:07Z","timestamp":1787962927172,"version":"build-2784847793"},"reference-count":70,"publisher":"European Respiratory Society (ERS)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2013,12,27]]},"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:p>The prognosis of patients with malignant pleural mesothelioma remains poor and although it is clear that multimodal therapy is necessary to improve long-term results, precise treatment schemes have not yet been unequivocally established. Single-modality therapy does not have a major impact on long-term survival and combined-modality therapies are being further evaluated. However, the relative contributions of chemotherapy, radiotherapy and surgery have not been clearly determined at the present time. Moreover, the extent of resection and precise surgical procedure remain a highly debated topic. To better compare and combine results from different institutions and trials, uniform definitions of surgical procedures including extrapleural pneumonectomy and different forms of pleurectomy have recently been introduced. Due to the relatively higher morbidity and mortality of extrapleural pneumonectomy, there is currently a shift towards pleurectomy\/decortication when a macroscopic complete resection of all tumour can be obtained by this procedure. In most recent trials, induction chemotherapy was administered to improve surgical resection rates but pathological complete responses are infrequently observed. The role of post-operative radiotherapy has to be further elucidated.<\/jats:p><jats:p>Further treatment options that are currently explored include hyperthermic intrapleural chemotherapy, immunotherapy, gene therapy and photodynamic therapy. However, no randomised comparisons are available yet.<\/jats:p>","DOI":"10.1183\/09031936.00207213","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T08:17:56Z","timestamp":1392365876000},"page":"754-764","source":"Crossref","is-referenced-by-count":37,"title":["Multimodal management of malignant pleural mesothelioma: where are we today?"],"prefix":"10.1183","volume":"44","author":[{"given":"Paul E.","family":"Van Schil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Weder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"De Laet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Domen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lauwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen M.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Van Meerbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2014,2,13]]},"reference":[{"key":"2024102022320524000_44.3.754.1","first-page":"11","article-title":"Arsenic, metals, fibres, and dusts","volume":"100","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"2024102022320524000_44.3.754.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1759-7714.2012.00127.x"},{"key":"2024102022320524000_44.3.754.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00168111"},{"key":"2024102022320524000_44.3.754.4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.4.1122"},{"issue":"Suppl. 1","key":"2024102022320524000_44.3.754.5","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.lungcan.2005.03.008","article-title":"Malignant pleural mesothelioma: staging systems","volume":"49","author":"Van Schil","year":"2005","journal-title":"Lung Cancer"},{"key":"2024102022320524000_44.3.754.6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh059"},{"key":"2024102022320524000_44.3.754.7","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318269fe21"},{"key":"2024102022320524000_44.3.754.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.08.005"},{"key":"2024102022320524000_44.3.754.9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00146110"},{"key":"2024102022320524000_44.3.754.10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds535"},{"key":"2024102022320524000_44.3.754.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2012.12.004"},{"key":"2024102022320524000_44.3.754.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2013.01.039"},{"key":"2024102022320524000_44.3.754.13","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31826915f1"},{"key":"2024102022320524000_44.3.754.14","first-page":"132","article-title":"Treatment of mesothelioma: still a long way to go","volume":"25","author":"Van Schil","year":"2013","journal-title":"Chin J Cancer Res"},{"key":"2024102022320524000_44.3.754.15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","article-title":"Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience","volume":"16","author":"Curran","year":"1998","journal-title":"J Clin Oncol"},{"key":"2024102022320524000_44.3.754.16","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.3.723"},{"key":"2024102022320524000_44.3.754.17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.1359"},{"key":"2024102022320524000_44.3.754.18","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7015"},{"issue":"Suppl.","key":"2024102022320524000_44.3.754.19","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1200\/jco.2013.31.15_suppl.7587","article-title":"A clinical-based risk score for decision making for surgery after induction chemotherapy in maignant pleural mesothelioma patients.","volume":"31","author":"Opitz","year":"2013","journal-title":"J Clin Oncol"},{"key":"2024102022320524000_44.3.754.20","first-page":"438","article-title":"Do we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC database","volume":"1","author":"Rusch","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"2024102022320524000_44.3.754.21","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182730e0e"},{"key":"2024102022320524000_44.3.754.22","doi-asserted-by":"crossref","unstructured":"Meuris K Hertoghs M Lauwers P . Subtotal pleurectomy by video-assisted thoracic surgery for metastatic pleuritis. MMCTS 2012; mms008: 10.1093\/mmcts\/mms008.","DOI":"10.1093\/mmcts\/mms008"},{"key":"2024102022320524000_44.3.754.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2004.08.014"},{"issue":"Suppl. 2","key":"2024102022320524000_44.3.754.24","first-page":"S2","article-title":"MesoVATS: a multi-centre randomised controlled trial of video-assited thoracoscopic pleurectomy versus talc pleurodesis in malignant pleural mesothelioma","volume":"8","author":"Rintoul","year":"2013","journal-title":"J Thorac Oncol"},{"key":"2024102022320524000_44.3.754.25","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(00)00422-X"},{"key":"2024102022320524000_44.3.754.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2008.06.009"},{"key":"2024102022320524000_44.3.754.27","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182208e3f"},{"key":"2024102022320524000_44.3.754.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(02)00033-6"},{"key":"2024102022320524000_44.3.754.29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"2024102022320524000_44.3.754.30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20005.14.589"},{"key":"2024102022320524000_44.3.754.31","first-page":"CD005574","article-title":"Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma","volume":"1","author":"Green","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102022320524000_44.3.754.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(99)70469-1"},{"key":"2024102022320524000_44.3.754.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2007.10.054"},{"key":"2024102022320524000_44.3.754.34","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2001.116560"},{"key":"2024102022320524000_44.3.754.35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.3.754"},{"key":"2024102022320524000_44.3.754.36","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601957"},{"key":"2024102022320524000_44.3.754.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2009.06.014"},{"key":"2024102022320524000_44.3.754.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2007.05.022"},{"key":"2024102022320524000_44.3.754.39","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3282fcea50"},{"key":"2024102022320524000_44.3.754.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2006.06.002"},{"key":"2024102022320524000_44.3.754.41","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm093"},{"key":"2024102022320524000_44.3.754.42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.5604"},{"key":"2024102022320524000_44.3.754.43","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00039510"},{"key":"2024102022320524000_44.3.754.44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.3943"},{"key":"2024102022320524000_44.3.754.45","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318156af3b"},{"key":"2024102022320524000_44.3.754.46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1510\/icvts.2005.123430","article-title":"The MARS trial: mesothelioma and radical surgery","volume":"5","author":"Treasure","year":"2006","journal-title":"Interac Cardiovas Thoracic Surg"},{"key":"2024102022320524000_44.3.754.47","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181ae26ae"},{"key":"2024102022320524000_44.3.754.48","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70149-8"},{"key":"2024102022320524000_44.3.754.49","first-page":"P3.22","article-title":"Randomised trial of extended pleurectomy and decortication (EPD) with pemetrexed and platinum chemotherapy versus pemetrexed and platinum alone in patients with malignant pleural mesothelioma (\u201cMARS-2\u201d)","volume":"2012","author":"Steele","year":"2012","journal-title":"Proc IMIG"},{"key":"2024102022320524000_44.3.754.50","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(11)70307-2","article-title":"The MARS feasibility trial: conclusions not supported by data","volume":"12","author":"Weder","year":"2011","journal-title":"Lancet Oncol"},{"key":"2024102022320524000_44.3.754.51","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181ed0489"},{"key":"2024102022320524000_44.3.754.52","first-page":"428","article-title":"Systematic review of trimodality therapy for patients with malignant pleural mesothelioma","volume":"1","author":"Cao","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"2024102022320524000_44.3.754.53","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/JTO.0b013e31828353d7","article-title":"Surgery in mesothelioma\u2013where do we go after MARS","volume":"8","author":"Hiddinga","year":"2013","journal-title":"J Thorac Oncol"},{"key":"2024102022320524000_44.3.754.54","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31824ab6c5"},{"key":"2024102022320524000_44.3.754.55","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31824d9a52"},{"key":"2024102022320524000_44.3.754.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.04.024"},{"key":"2024102022320524000_44.3.754.57","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00063109"},{"key":"2024102022320524000_44.3.754.58","unstructured":"Asbestos Diseases Research Institute. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. www.adri.org.au\/documents\/Guidelines_for_the_diagnosis_and_treatment_of_malignant_pleural_mesothelioma.pdf Date last accessed: 2013. Date last updated: July 2013."},{"key":"2024102022320524000_44.3.754.59","unstructured":"Swiss Group for Clinical Cancer Research. Project Group Lung Cancer. http:\/\/sakk.ch\/en\/about-sakk\/organization\/research-groups\/project-group-lung-cancer\/ Date last accessed: January 25, 2014. Date last updated: 2014."},{"key":"2024102022320524000_44.3.754.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2007.04.076"},{"key":"2024102022320524000_44.3.754.61","unstructured":"Memorial Sloan-Kettering Cancer Center. Study Using Chemotherapy +\/- Pleurectomy\/Decortication Followed By Intensity Modulated Radiation Therapy. www.clinicaltrials.gov\/ct2\/show\/NCT00715611 Date last accessed: January 25, 2014. Date last updated: January 17, 2014."},{"key":"2024102022320524000_44.3.754.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.09.027"},{"issue":"Suppl. 2","key":"2024102022320524000_44.3.754.63","first-page":"S345","article-title":"Five-year experience with accelerated induction hypofractionated hemithoracic intensity modulated radiation therapy (IMRT) followed by extrapleural pneumonectomy (EPP) for malignant pleural mesothelioma (MPM)","volume":"8","author":"De Perrot","year":"2013","journal-title":"J Thorac Oncol"},{"key":"2024102022320524000_44.3.754.64","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182288af9"},{"key":"2024102022320524000_44.3.754.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2012.12.037"},{"key":"2024102022320524000_44.3.754.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2013.04.007"},{"issue":"Suppl. 2","key":"2024102022320524000_44.3.754.67","first-page":"S343","article-title":"Intracavitary cisplatin-fibrin chemotherapy after resection for malignant pleural mesothelioma patients (Influence-meso) \u2013 preliminary results","volume":"8","author":"Opitz","year":"2013","journal-title":"J Thorac Oncol"},{"key":"2024102022320524000_44.3.754.68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2005.00714.x"},{"key":"2024102022320524000_44.3.754.69","first-page":"472","article-title":"Radical pleurectomy and photodynamic therapy for malignant pleural mesothelioma","volume":"1","author":"Friedberg","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"2024102022320524000_44.3.754.70","first-page":"P4.14","article-title":"EORTC randomised phase II study of extended pleurectomy\/decortication (e-P\/D) preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (MPM)","volume":"2012","author":"Lang-Lazdunski","year":"2012","journal-title":"Proc IMIG"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/09031936.00207213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:48:17Z","timestamp":1740379697000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/09031936.00207213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,13]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,8,31]]},"published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1183\/09031936.00207213"],"URL":"https:\/\/doi.org\/10.1183\/09031936.00207213","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,13]]}}}